These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 4287392)

  • 1. Immunological studies with group B arthropod-borne viruses. V. Evaluation of cross-immunity against type 1 dengue fever in human subjects convalescent from subclinical natural Japanese encephalitis virus infection and vaccinated with 17D strain yellow fever vaccine.
    Wisseman CL; Kitaoka M; Tamiya T
    Am J Trop Med Hyg; 1966 Jul; 15(4):588-600. PubMed ID: 4287392
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunological studies with group B arthropod-borne viruses. VI. Hemagglutination-inhibiting antibody responses to 17D yellow fever vaccine in human subjects with different degrees of complexity of pre-vaccination group B virus experience.
    Hatgi JN; Wisseman CL; Rosenzweig EC; Harrington BR; Kitaoka M
    Am J Trop Med Hyg; 1966 Jul; 15(4):601-10. PubMed ID: 5941178
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunological studies with group B arthropod-borne viruses. I. Broadened neutralizing antibody spectrum induced by strain 17D yellow fever vaccine in human subjects previously infected with Japanese encephalitis virus.
    WISSEMAN CL; SWEET BH; KITAOKA M; TAMIYA T
    Am J Trop Med Hyg; 1962 Jul; 11():550-61. PubMed ID: 14007700
    [No Abstract]   [Full Text] [Related]  

  • 4. Research on dengue in tissue culture. IV. Serologic responses of human beings to combined inoculations of attenuated, tissue-cultured type I dengue virus and yellow fever vaccine.
    Fujita N; Oda K; Yasui Y; Hotta S
    Kobe J Med Sci; 1969 Dec; 15(4):163-80. PubMed ID: 4317037
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunological studies with group B arthropod-borne viruses. III. Response of human subjects to revaccination with 17D strain yellow fever vaccine.
    WISSEMAN CL; SWEET BH
    Am J Trop Med Hyg; 1962 Jul; 11():570-5. PubMed ID: 14007701
    [No Abstract]   [Full Text] [Related]  

  • 6. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
    Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
    J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of hemagglutination-inhibiting antibodies to arboviruses in sera of young individuals in the Federal Republic of Germany and in the Republic of Togo (West Africa)].
    Ebke J; Schäfer E
    Zentralbl Bakteriol Orig A; 1971 Oct; 218(2):149-59. PubMed ID: 4403535
    [No Abstract]   [Full Text] [Related]  

  • 8. Sequential immunization procedure against Group B arboviruses using living attenuated 17D yellow fever virus, living attenuated Langat E5 virus, and living attenuated dengue 2 virus (New Guinea C isolate).
    Price WH; Casals J; Thind I; O'Leary W
    Am J Trop Med Hyg; 1973 Jul; 22(4):509-23. PubMed ID: 4352231
    [No Abstract]   [Full Text] [Related]  

  • 9. [Survey with human sera from West Cameroon (author's transl)].
    Radda A
    Zentralbl Bakteriol Orig A; 1973 Dec; 225(2):375-80. PubMed ID: 4150072
    [No Abstract]   [Full Text] [Related]  

  • 10. Japanese encephalitis vaccine including a preliminary report on dengue fever and Chikungunya vaccines.
    Kitaoka M
    Jpn J Med Sci Biol; 1967 Dec; 20 Suppl():41-56. PubMed ID: 4297905
    [No Abstract]   [Full Text] [Related]  

  • 11. Blood value changes in flavivirus-inoculated Macaca fascicularis monkeys.
    Angsubhakorn S; Yoksan S; Henchal EA; Nisalak A; Hoke CH; Pradermwong A; Sahaphong S; Bhamarapravati N
    Southeast Asian J Trop Med Public Health; 1986 Mar; 17(1):1-7. PubMed ID: 2874612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological studies on a case of laboratory dengue infection.
    Okuno Y; Fukunaga T; Tadano M; Fukai K
    Biken J; 1982 Dec; 25(4):163-70. PubMed ID: 6307255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates.
    Guirakhoo F; Pugachev K; Arroyo J; Miller C; Zhang ZX; Weltzin R; Georgakopoulos K; Catalan J; Ocran S; Draper K; Monath TP
    Virology; 2002 Jun; 298(1):146-59. PubMed ID: 12093182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
    Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
    Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yellow fever outbreak in Ipetu-Ijesa: response after mass vaccination.
    Adu FD; Adeniji JA; Tomori O; Adelasoye A
    Rev Roum Virol; 1993; 44(1-2):3-7. PubMed ID: 8043476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arbovirus group B spectrum in the province of Brokopondo, Surinam. A serological survey.
    van Tongeren HA
    Trop Geogr Med; 1965 Dec; 17(4):339-52. PubMed ID: 5884327
    [No Abstract]   [Full Text] [Related]  

  • 17. [The standardization of the plaque reduction technic for differentiating a dengue infection from a yellow fever infection].
    Alvarez Vera M; Valdés Palacios D; Vázquez Ramudo S; Delgado Hernández I; García Infante S; Morier Díaz L; Guzmán Tirado MG
    Rev Cubana Med Trop; 1998; 50(3):177-81. PubMed ID: 10349439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological evidence of arbovirus infection in febrile hospitalized patients in Jakarta, Indonesia during 1970-71.
    Van Peenen PF; Anderson KE; See R; Nasution R
    J Trop Med Hyg; 1974 Oct; 77(10):244-6. PubMed ID: 4374556
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects.
    Guy B; Nougarede N; Begue S; Sanchez V; Souag N; Carre M; Chambonneau L; Morrisson DN; Shaw D; Qiao M; Dumas R; Lang J; Forrat R
    Vaccine; 2008 Oct; 26(45):5712-21. PubMed ID: 18762226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination against mosquito borne viral infections: current status.
    Wiwanitkit V
    Iran J Immunol; 2007 Dec; 4(4):186-96. PubMed ID: 18057576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.